Works about EMTRICITABINE

Results: 409
    1
    2
    3

    Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.

    Published in:
    2020
    By:
    • Sculier, Delphine;
    • Wandeler, Gilles;
    • Yerly, Sabine;
    • Marinosci, Annalisa;
    • Stoeckle, Marcel;
    • Bernasconi, Enos;
    • Braun, Dominique L.;
    • Vernazza, Pietro;
    • Cavassini, Matthias;
    • Buzzi, Marta;
    • Metzner, Karin J.;
    • Decosterd, Laurent A.;
    • Günthard, Huldrych F.;
    • Schmid, Patrick;
    • Limacher, Andreas;
    • Egger, Matthias;
    • Calmy, Alexandra;
    • and the Swiss HIV Cohort Study (SHCS);
    • Swiss HIV Cohort Study (SHCS)
    Publication type:
    journal article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir.

    Published in:
    PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0289132
    By:
    • Squillace, Nicola;
    • Ricci, Elena;
    • Maggi, Paolo;
    • Taramasso, Lucia;
    • Menzaghi, Barbara;
    • De Socio, Giuseppe Vittorio;
    • Piconi, Stefania;
    • Maurizio Celesia, Benedetto;
    • Orofino, Giancarlo;
    • Sarchi, Eleonora;
    • Pellicanò, Giovanni Francesco;
    • Simeone, Filomena;
    • Valsecchi, Laura;
    • Bandera, Alessandra;
    • Cenderello, Giovanni;
    • Attala, Letizia;
    • Angioni, Goffredo;
    • Falasca, Katia;
    • Cascio, Antonio;
    • Bargiacchi, Olivia
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).

    Published in:
    2017
    By:
    • Gulick, Roy M.;
    • Wilkin, Timothy J.;
    • Chen, Ying Q.;
    • Landovitz, Raphael J.;
    • Amico, K. Rivet;
    • Young, Alicia M.;
    • Richardson, Paul;
    • Marzinke, Mark A.;
    • Hendrix, Craig W.;
    • Eshleman, Susan H.;
    • McGowan, Ian;
    • Cottle, Leslie M.;
    • Andrade, Adriana;
    • Marcus, Cheryl;
    • Klingman, Karin L.;
    • Chege, Wairimu;
    • Rinehart, Alex R.;
    • Rooney, James F.;
    • Andrew, Philip;
    • Salata, Robert A.
    Publication type:
    journal article
    26
    27
    28

    Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.

    Published in:
    2015
    By:
    • Gandhi, Monica;
    • Glidden, David V.;
    • Liu, Albert;
    • Anderson, Peter L.;
    • Horng, Howard;
    • Defechereux, Patricia;
    • Guanira, Juan V.;
    • Grinsztejn, Beatriz;
    • Chariyalertsak, Suwat;
    • Bekker, Linda-Gail;
    • Grant, Robert M.;
    • iPrEx Study Team
    Publication type:
    journal article
    29
    30
    31
    32

    Abacavir/Lamivudine Versus Tenofovir DF/ Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results.

    Published in:
    Journal of Infectious Diseases, 2011, v. 204, n. 8, p. 1191, doi. 10.1093/infdis/jir505
    By:
    • Sax, Paul E.;
    • Tierney, Camlin;
    • Collier, Ann C.;
    • Daar, Eric S.;
    • Mollan, Katie;
    • Budhathoki, Chakra;
    • Godfrey, Catherine;
    • Jahed, Nasreen C.;
    • Myers, Laurie;
    • Katzenstein, David;
    • Farajallah, Awny;
    • Rooney, James F.;
    • Ha, Belinda;
    • Woodward, William C.;
    • Feinberg, Judith;
    • Tashima, Karen;
    • Murphy, Robert L.;
    • Fischl, Margaret A.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.

    Published in:
    Journal of Personalized Medicine, 2023, v. 13, n. 4, p. 583, doi. 10.3390/jpm13040583
    By:
    • Sellem, Baptiste;
    • Abdi, Basma;
    • Lê, Minh;
    • Tubiana, Roland;
    • Valantin, Marc-Antoine;
    • Seang, Sophie;
    • Schneider, Luminita;
    • Fayçal, Antoine;
    • Peytavin, Gilles;
    • Soulié, Cathia;
    • Marcelin, Anne-Geneviève;
    • Katlama, Christine;
    • Pourcher, Valérie;
    • Palich, Romain
    Publication type:
    Article
    49
    50